| Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 36.63 mm | 36.63 mm | 36.63 mm | 36.63 mm | 36.63 mm | 36.63 mm |
| Cash burn (monthly) | 3.51 mm | 278.75 k | 2.67 mm | 1.23 mm | (no burn) | 347.58 k |
| Cash used (since last report) | 9.89 mm | 785.32 k | 7.52 mm | 3.47 mm | n/a | 979.24 k |
| Cash remaining | 26.74 mm | 35.85 mm | 29.11 mm | 33.17 mm | n/a | 35.65 mm |
| Runway (months of cash) | 7.6 | 128.6 | 10.9 | 27.0 | n/a | 102.6 |
| 13F holders | Current |
|---|---|
| Total holders | 52 |
| Opened positions | 19 |
| Closed positions | 8 |
| Increased positions | 13 |
| Reduced positions | 8 |
| 13F shares | Current |
|---|---|
| Total value | 13.30 bn |
| Total shares | 3.97 mm |
| Total puts | 8.20 k |
| Total calls | 274.80 k |
| Total put/call ratio | 0.0 |
| Largest owners | Shares | Value |
|---|---|---|
| Vanguard | 885.88 k | $3.84 bn |
| Rice Hall James & Associates | 849.29 k | $3.69 bn |
| Apexian Pharmaceuticals | 779.99 k | $4.68 mm |
| Richmond Brothers | 341.86 k | $1.48 bn |
| Geode Capital Management | 194.05 k | $842.17 mm |
| Knoll Capital Management | 100.00 k | $434.00 mm |
| Renaissance Technologies | 99.60 k | $432.00 k |
| BLK BlackRock | 55.40 k | $240.43 mm |
| STT State Street | 52.87 k | $229.47 mm |
| Stratos Wealth Partners | 49.20 k | $213.51 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 23 Dec 24 | George Magrath | Common Stock | Grant | Acquire A | No | No | 0 | 6,200 | 0.00 | 499,150 |
| 21 Nov 24 | Benjamin R Yerxa | Common Stock | Buy | Acquire P | No | No | 0.9834 | 10,000 | 9.83 k | 342,800 |
| 18 Nov 24 | George Magrath | Common Stock | Buy | Acquire P | No | No | 1.0244 | 9,706 | 9.94 k | 492,950 |
| 15 Nov 24 | George Magrath | Common Stock | Buy | Acquire P | No | No | 1.0102 | 90,294 | 91.21 k | 483,244 |
| 7 Nov 24 | Benjamin R Yerxa | Common Stock | Grant | Acquire A | No | No | 0 | 332,800 | 0.00 | 332,800 |
| 1 Nov 24 | George Magrath | Common Stock | Payment of exercise | Dispose F | No | No | 1.18 | 37,050 | 43.72 k | 392,950 |
